Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
GPCR Desensitization01:12

GPCR Desensitization

6.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.5K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.4K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.4K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.4K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter to the Editor regarding "Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays".

Headache·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays.

Headache·2025
Same author

Development and pharmacological characterization of novel multi- calcitonin gene-related peptide and pituitary adenylate cyclase-activating peptide receptor antagonists.

Headache·2025
Same author

Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine.

Nature reviews. Neurology·2024
Same author

Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain Macrocyclization.

Journal of the American Chemical Society·2024
Same journal

Differential thalamic GSH/Glu ratios Among primary headache subtypes and clinical implications: A cross-sectional magnetic resonance spectroscopy study.

Cephalalgia : an international journal of headache·2026
Same journal

<i>In Vivo</i> confocal microscopy evaluation of corneal layer alterations in patients with trigeminal neuralgia.

Cephalalgia : an international journal of headache·2026
Same journal

Early and clinically meaningful functional improvement following CGRP monoclonal antibodies in adolescents with migraine: A real-world retrospective study.

Cephalalgia : an international journal of headache·2026
Same journal

Iatrogenic harm in paediatric and adolescent populations of patients with migraine: A systematic review with meta-analysis.

Cephalalgia : an international journal of headache·2026
Same journal

Rimegepant for migraine prevention in clinical practice: A multicenter study including patients with prior anti-CGRP monoclonal antibody failure (GEMA project).

Cephalalgia : an international journal of headache·2026
Same journal

Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program.

Cephalalgia : an international journal of headache·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

309

Decoding PACAP signaling: Splice variants, pathways and designer drugs.

Zoe Tasma1, Debbie L Hay1

  • 1Department of Pharmacology and Toxicology, The University of Otago, Dunedin, New Zealand.

Cephalalgia : an International Journal of Headache
|August 6, 2025
PubMed
Summary
This summary is machine-generated.

Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are key in neurological signaling and linked to headaches. Understanding their complex receptor interactions offers new therapeutic targets for migraine and other headache disorders.

Keywords:
G protein-coupled receptorMRGPACAPVIPmigraineneuropeptide

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.1K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.9K

Related Experiment Videos

Last Updated: Sep 12, 2025

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

309
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.1K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.9K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are neuropeptides involved in vasodilation, immune response, and neuronal signaling.
  • These peptides have been recently linked to headache disorders, particularly migraine, driving interest in their therapeutic potential.
  • PACAP and VIP exert their effects through G protein-coupled receptors (GPCRs), including canonical receptors (PAC1, VPAC1, VPAC2) and potentially others (GPR55, MRGPRX2).

Purpose of the Study:

  • To provide a comprehensive overview of the PACAP/VIP system, focusing on peptide, receptor, and downstream signaling mechanisms.
  • To explore the complexities of PACAP/VIP receptor variants and their potential functional alterations.
  • To identify potential therapeutic targets within the PACAP/VIP system for headache disorders and related conditions.

Main Methods:

  • This is a narrative review, synthesizing existing research on the PACAP/VIP system.
  • Literature search and analysis of studies investigating PACAP/VIP peptides, their receptors, and signaling pathways.
  • Focus on studies relevant to headache disorders and drug development.

Main Results:

  • The PACAP/VIP system is complex, involving multiple canonical and proposed receptors, as well as potential receptor variants.
  • PACAP can activate various receptors, including PAC1, VPAC1, VPAC2, GPR55, and MRGPRX2, contributing to diverse biological actions.
  • There is a limited understanding of the downstream signaling, cellular localization, and accessory protein interactions of these receptors in migraine-relevant contexts.

Conclusions:

  • The intricate nature of the PACAP/VIP system presents both challenges and opportunities for drug design and validation.
  • Targeting specific components of the PACAP/VIP pathway, including its receptors and signaling cascades, holds promise for novel headache disorder treatments.
  • Further research into the functional mechanisms of PACAP/VIP receptors is crucial for developing effective "designer" therapeutics.